BCWM
IMGN

Bartlett & Co Wealth Management’s Immunogen Inc IMGN Stock Holding History

Bartlett & Co Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-97
Closed -$210 – 950
2019
Q2 		$210 Buy
+97
New +$229 ﹤0.01% 747

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bartlett & Co Wealth Management's IMGN Position: Q3 2019 in Review

Bartlett & Co Wealth Management sold out of Immunogen Inc (IMGN) in Q3 2019, closing a stake of 97 shares — an estimated $210 sold.

Bartlett & Co Wealth Management first reported a position in IMGN in Q2 2019 and held it in 1 quarter. The position peaked at $210 in Q2 2019. 189 funds tracked by Wall St. Rank hold IMGN as of Q3 2019.

  • Bartlett & Co Wealth Management reported no remaining Immunogen Inc position as of Q3 2019 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 97 Immunogen Inc shares in Q3 2019, an estimated $210.
  • Bartlett & Co Wealth Management first reported a position in Immunogen Inc in Q2 2019 and held it in 1 quarter.
  • Bartlett & Co Wealth Management's Immunogen Inc position peaked at $210 in Q2 2019.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2019.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2019, filed 13 Feb 2024.